Targeting of C‐type lectin‐like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: reply. (18th November 2017) - Delierneux, C.; Donis, N.; Servais, L.; Wéra, O.; Lancellotti, P.; Oury, C.